Literature DB >> 3500640

Pharyngeal carriage and acquisition of anticapsular antibody to Haemophilus influenzae type b in a high-risk population in southwestern Alaska.

D B Hall1, M K Lum, L R Knutson, W L Heyward, J I Ward.   

Abstract

Haemophilus influenzae type b disease in Alaskan Eskimos is characterized by greatly increased disease incidence at younger ages. This suggests that Eskimo infants have increased exposure to the disease. Exposure was studied in 1982-1983 in children less than age three years who lived in four Eskimo villages, as well as in a random sample of their family members (354 people from 132 households). During a 12-month period, up to four pharyngeal cultures and two serum specimens were obtained from each participant. Colonization with H. influenzae type b was relatively uncommon (overall 2.5% of cultures, 6.8% of individuals) and was not associated with age, sex, season, or prior incidence of disease in the village. Biotyping and outer-membrane-protein typing of H. influenzae type b isolates revealed homogeneity within villages, with differences between villages. Matched sera revealed a significant decline in H. influenzae type b capsular antibody in the course of the study year. However, pharyngeal carriage of H. influenzae type b was associated with increases in antibody for carriers and members of their households. Antibody levels were positively associated with age. Only one case of H. influenzae type b disease developed during the study. Low carriage of H. influenzae type b was coincident with low incidence of disease and declining levels of capsular antibody in these villages. Mechanisms for increased exposure which would not be reflected in high carriage rates may exist for these young children.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500640     DOI: 10.1093/oxfordjournals.aje.a114758

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali.

Authors:  Julia Hutter; Marcela F Pasetti; Doh Sanogo; Milagritos D Tapia; Samba O Sow; Myron M Levine
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.

Authors:  Henry C Baggett; Thomas W Hennessy; Lisa Bulkow; Sandra Romero-Steiner; Debra Hurlburt; Patricia Holder; Alan J Parkinson; Rosalyn J Singleton; Orin Levine; George M Carlone; Jay C Butler
Journal:  Clin Vaccine Immunol       Date:  2006-06

3.  Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

Authors:  J McVernon; M E Ramsay; A R McLean
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

Review 4.  Conjugate vaccines and the carriage of Haemophilus influenzae type b.

Authors:  M L Barbour
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

Review 5.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 6.  A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.

Authors:  R S W Tsang; M G Bruce; M Lem; L Barreto; M Ulanova
Journal:  Epidemiol Infect       Date:  2014-03-05       Impact factor: 4.434

7.  Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.

Authors:  Michael G Bruce; Tammy Zulz; Carolynn DeByle; Ros Singleton; Debby Hurlburt; Dana Bruden; Karen Rudolph; Thomas Hennessy; Joseph Klejka; Jay D Wenger
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.